SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-20-002809
Filing Date
2020-11-13
Accepted
2020-11-13 17:12:06
Documents
52
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clcs_10q.htm 10-Q 633010
2 EX-10.54 clcs_ex1054.htm EX-10.54 53618
3 EX-10.55 clcs_ex1055.htm EX-10.55 59542
4 EX-10.56 clcs_ex1056.htm EX-10.56 36272
5 EX-10.57 clcs_ex1057.htm EX-10.57 36368
6 EX-10.58 clcs_ex1058.htm EX-10.58 34642
7 EX-10.59 clcs_ex1059.htm EX-10.59 55416
8 EX-31 clcs_ex31.htm EX-31 9926
9 EX-32 clcs_ex32.htm EX-32 3378
  Complete submission text file 0001640334-20-002809.txt   3348727

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT clcs-20200930.xml EX-101.INS 486181
11 XBRL TAXONOMY EXTENSION SCHEMA clcs-20200930.xsd EX-101.SCH 46738
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20200930_lab.xml EX-101.LAB 259026
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20200930_cal.xml EX-101.CAL 36824
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20200930_pre.xml EX-101.PRE 223100
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20200930_def.xml EX-101.DEF 159913
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 201312504
SIC: 2834 Pharmaceutical Preparations